236 related articles for article (PubMed ID: 23991236)
1. In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
Myburgh E; Coles JA; Ritchie R; Kennedy PG; McLatchie AP; Rodgers J; Taylor MC; Barrett MP; Brewer JM; Mottram JC
PLoS Negl Trop Dis; 2013; 7(8):e2384. PubMed ID: 23991236
[TBL] [Abstract][Full Text] [Related]
2. Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.
Rodgers J; Jones A; Gibaud S; Bradley B; McCabe C; Barrett MP; Gettinby G; Kennedy PG
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1308. PubMed ID: 21909447
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei.
Ritchie R; Barrett MP; Mottram JC; Myburgh E
Methods Mol Biol; 2020; 2116():801-817. PubMed ID: 32221957
[TBL] [Abstract][Full Text] [Related]
4. A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis.
Burrell-Saward H; Rodgers J; Bradley B; Croft SL; Ward TH
J Antimicrob Chemother; 2015 Feb; 70(2):510-7. PubMed ID: 25298516
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
Rodgers J; Stone TW; Barrett MP; Bradley B; Kennedy PG
Brain; 2009 May; 132(Pt 5):1259-67. PubMed ID: 19339256
[TBL] [Abstract][Full Text] [Related]
6. Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase.
McLatchie AP; Burrell-Saward H; Myburgh E; Lewis MD; Ward TH; Mottram JC; Croft SL; Kelly JM; Taylor MC
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2571. PubMed ID: 24278497
[TBL] [Abstract][Full Text] [Related]
7. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
Rottenberg ME; Masocha W; Ferella M; Petitto-Assis F; Goto H; Kristensson K; McCaffrey R; Wigzell H
J Infect Dis; 2005 Nov; 192(9):1658-65. PubMed ID: 16206083
[TBL] [Abstract][Full Text] [Related]
8. Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains.
Montague P; Bradley B; Rodgers J; Kennedy PGE
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009892. PubMed ID: 34762691
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
10. Development of novel drugs for human African trypanosomiasis.
Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
[TBL] [Abstract][Full Text] [Related]
11. Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis.
Rodgers J; Bradley B; Kennedy PGE
Methods; 2017 Aug; 127():79-87. PubMed ID: 28636879
[TBL] [Abstract][Full Text] [Related]
12. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
[TBL] [Abstract][Full Text] [Related]
13. Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.
Jennings FW; Gray GD
Contrib Microbiol Immunol; 1983; 7():147-54. PubMed ID: 6825436
[TBL] [Abstract][Full Text] [Related]
14. Imaging African trypanosomes.
MacLean L; Myburgh E; Rodgers J; Price HP
Parasite Immunol; 2013; 35(9-10):283-94. PubMed ID: 23790101
[TBL] [Abstract][Full Text] [Related]
15. Development of Trypanosoma brucei in suckling mouse brain following intracerebral injection.
Bafort JM; Schmidt H; Molyneux DH
Trans R Soc Trop Med Hyg; 1987; 81(3):487-90. PubMed ID: 3686641
[TBL] [Abstract][Full Text] [Related]
16. Early invasion of brain parenchyma by African trypanosomes.
Frevert U; Movila A; Nikolskaia OV; Raper J; Mackey ZB; Abdulla M; McKerrow J; Grab DJ
PLoS One; 2012; 7(8):e43913. PubMed ID: 22952808
[TBL] [Abstract][Full Text] [Related]
17. A panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection models.
Van Reet N; Van de Vyver H; Pyana PP; Van der Linden AM; Büscher P
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3054. PubMed ID: 25144573
[TBL] [Abstract][Full Text] [Related]
18. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA
J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919
[TBL] [Abstract][Full Text] [Related]
19. Trypanocidal activity of blood and tissue fluid from normal and infected rabbits treated with curative drugs.
Goodwin LG; Tierney ED
Parasitology; 1977 Feb; 74(1):33-45. PubMed ID: 840497
[TBL] [Abstract][Full Text] [Related]
20. Effects of Trypanosoma brucei infection and diminazene aceturate therapy on testicular morphology and function of Nigerian local dogs.
Obi CF; Obidike RI; Ezeh IO; Omoja VU; Iheagwam CN; Idika IK; Ezeokonkwo RC
Vet Parasitol; 2013 Sep; 196(3-4):283-8. PubMed ID: 23639198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
